23andMe offers DNA testing with the most comprehensive ancestry breakdown, personalized health insights and more.

23andMe is a genetics and health company that believes you should be able to access, understand and benefit from all the endlessly interesting things your DNA can tell you.`

It’s soft. It’s comfortable. And it features the best looking logo that we know of. • 100% combed ringspun cotton ; Heather Dark Grey is 35% combed ringspun cotton and 65% polyester • Classic semi-contoured silhouette with side seam • Tear-away label • Shoulder-to-shoulder taping • Seamed collarette

23andMe was founded in 2006 to help people access, understand and benefit from the human genome. We have more than three million genotyped customers around the world.

23andMe is the first direct-to-consumer test that includes FDA-authorized health reports. 23andMe was founded in 2006 to help people access, understand and benefit from the human genome.

23andMe is a genetics and health company that believes you should be able to access, understand and benefit from all the endlessly interesting things your DNA can tell you.`

You can add information about your ancestors* to your pedigree by following the instructions below:. In the Share and Compare feature, click the place in the tree that correctly represents their relationship to you.; If the relative is sharing genomes with you, select his or her name from the Connections dropdown menu.

Access your 23andMe® reports, connect with family and friends, and help drive scientific and medical discoveries wherever you go with the 23andMe mobile app. The 23andMe mobile app is available for...

* The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports which are based on 23andMe research and have not been reviewed by the FDA.

Jul 29, 2020 · This month marks the two-year anniversary of 23andMe’s collaboration with GlaxoSmithKline (GSK). In July 2018 the two joined forces to focus on increasing the probability of success in drug development by prioritizing candidates validated by human genetics.. Studies show that treatments that have been validated with genetic data are at least twice as likely to succeed when compared to ...